☆ 4.7 Review

APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer's disease

FRONTIERS IN PHARMACOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Neurosciences

Adult Neural Stem Cell Migration Is Impaired in a Mouse Model of Alzheimer's Disease

Daniel Esteve et al.

Summary: Neurogenesis and neuronal migration in the adult brain are impaired in Alzheimer's disease, leading to cell senescence and reduced odor discrimination ability. Studying the APP/PS1 Alzheimer's mouse model may provide insights for new Alzheimer's treatments based on senolytic compounds or pro-neurogenic factors.

MOLECULAR NEUROBIOLOGY (2022)

添加到收藏夹

Review Cell Biology

Neurogenesis in aging and age-related neurodegenerative diseases

Luka Culig et al.

Summary: Adult neurogenesis is a potential target for extending cognitive healthspan, as aging is a major risk factor for neurodegenerative diseases. This review describes the role of adult neurogenesis in neurodegenerative diseases and discusses the molecular mechanisms involving key proteins. Interventions that increase neurogenesis and regulate aging research targets are summarized, and the outlook for restoring neurogenesis levels in elderly individuals and those with neurodegeneration is shared.

AGEING RESEARCH REVIEWS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration

Rebeca Lapresa et al.

Summary: This study found that oligomers of the amyloidogenic fragment 25-35 of the A beta peptide trigger Rock2 accumulation and activation. The activation of Rock2 is caused by the inactivation of Cdh1 through the Cdk5-Cdh1 signaling pathway. Inhibition of Rock2 activity rescues neuronal apoptosis and memory impairment caused by A beta 25-35 administration. This mechanism may contribute to neurodegeneration and memory loss in Alzheimer's disease.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Neurosciences

The role of Cdk5 in neurological disorders

Chuncao Ao et al.

Summary: Neurological disorders are a group of disorders caused by the malfunction of the central or peripheral nervous system, resulting in motor, sensory or cognitive impairments. Cyclin-dependent kinase 5 (Cdk5) plays a vital role in the development of the nervous system, but its aberrant activation can lead to pathological changes. It is associated with various neurological disorders, and inhibiting Cdk5 may have neuroprotective effects.

FRONTIERS IN CELLULAR NEUROSCIENCE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Model scenarios for cell cycle re-entry in Alzheimer's disease

Nishtha Pandey et al.

Summary: Alzheimer's disease is the most common neurodegenerative disease characterized by abnormal accumulation and aggregation of amyloid beta peptide. Current treatments can only alleviate symptoms. Research suggests that cell cycle re-entry in neurons may play a crucial role in the disease's progression and severity. This finding provides new insight into potential therapeutic approaches targeting cell cycle re-entry in Alzheimer's disease.

ISCIENCE (2022)

添加到收藏夹

Article Cell Biology

Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer's disease

Larissa Traxler et al.

Summary: This study investigated the metabolic changes and transcriptional alterations in sporadic Alzheimer's disease (AD) utilizing induced neurons (iNs) from AD patients. The pathological isoform switching of PKM2 was found to contribute to neuronal vulnerability and loss in AD. Chemical modulation of PKM2 could reverse these changes and enhance neuronal resilience against cell death.

CELL METABOLISM (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress

Saikat Dewanjee et al.

Summary: This article systematically evaluates the abnormal glucose metabolism associated with amyloid beta and phosphorylated tau accumulation in AD, and discusses the role of insulin signaling and mitochondrial dysfunction in the progression of AD pathology.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: Mechanisms and possible therapeutic interventions

Subhamita Maitra et al.

Summary: Despite being expressed in various tissues, the activity of Cdk5 is limited to the central nervous system. Cdk5 plays a crucial role in the pathogenesis of Alzheimer's disease by being abnormally overactivated, leading to the hyper-phosphorylation of ll-amyloid precursor protein and tau and contributing to the development of the disease. Inhibiting the activity of Cdk5-p25 could be a promising strategy for anti-AD therapeutics.

LIFE SCIENCES (2022)

添加到收藏夹

Article Neurosciences

Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: Integration of the glutamate/GABA-glutamine cycle

Jens Andersen et al.

Summary: Astrocytes play a significant role in the development of Alzheimer's disease. They collaborate closely with neurons through neurotransmitter recycling, which is essential for neurotransmission. The metabolic changes in astrocytes during Alzheimer's disease can have a profound impact on neurotransmitter recycling and deprive neurons of metabolic support, leading to synaptic dysfunction and neurodegeneration.

PROGRESS IN NEUROBIOLOGY (2022)

添加到收藏夹

Review Cell Biology

Role of Aβ in Alzheimer's-related synaptic dysfunction

Huiqin Zhang et al.

Summary: Synaptic dysfunction is closely related to Alzheimer's disease (AD), mainly due to the disruption caused by beta-amyloid (Aβ). Aβ disrupts glutamate receptors and mediates synaptic toxicity through multiple mechanisms. Synaptic dysfunction plays a critical role in cognitive impairment of AD.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Review Clinical Neurology

Alzheimer's disease drug development pipeline: 2022

Jeffrey Cummings et al.

Summary: Alzheimer's disease is a global health crisis, and there are numerous clinical trials and drugs in development to treat and improve the symptoms and progression of the disease. The pipeline of drug development includes a diverse array of treatments, including disease-modifying therapies, cognitive enhancing treatments, and drugs for neuropsychiatric symptoms. Advances in drug design, outcome measures, biomarker use, and trial conduct show promise in accelerating the delivery of new and improved treatments for Alzheimer's disease patients.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

添加到收藏夹

Review Neurosciences

New approaches to symptomatic treatments for Alzheimer's disease

Jeffrey Cummings

Summary: There have been no recent approvals of cognitive enhancing agents for Alzheimer's disease (AD), but there are several new drugs in trials, including those targeting neuropsychiatric symptoms. Progress is also being made in trial design and outcome measures.

MOLECULAR NEURODEGENERATION (2021)

添加到收藏夹

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

添加到收藏夹

Article Neurosciences

Evidences for Adult Hippocampal Neurogenesis in Humans

Elena P. Moreno-Jimenez et al.

Summary: The rodent hippocampus generates new neurons throughout life, but direct evidence of adult neurogenesis in humans remains elusive. Research indicates that adult hippocampal neurogenesis may persist until the 10th decade of human life, with marked impairments in patients with Alzheimer's disease. Methodological aspects in processing and analyzing postmortem human brain samples may limit the detection of markers of adult hippocampal neurogenesis, highlighting the need for strict controls in human studies.

JOURNAL OF NEUROSCIENCE (2021)

添加到收藏夹

Review Oncology

Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy

Wen-Hsuan Yang et al.

Summary: Recent research has provided important insights into the mechanisms determining the tumor and host immune responses to pharmacological perturbation of glutamine metabolism, pointing towards patient stratification and drug combination strategies to maximize the efficacy of glutamine metabolism inhibitors as cancer therapeutics.

TRENDS IN CANCER (2021)

添加到收藏夹

Article Neurosciences

Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 Mice

Kristen R. Hollinger et al.

JOURNAL OF ALZHEIMERS DISEASE (2020)

添加到收藏夹

Review Neurosciences

Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease

Bhanu Chandra Karisetty et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease

Elena P. Moreno-Jimenez et al.

NATURE MEDICINE (2019)

添加到收藏夹

Article Neurosciences

Amyloid-β promotes neurotoxicity by Cdk5-induced p53 stabilization

Rebeca Lapresa et al.

NEUROPHARMACOLOGY (2019)

添加到收藏夹

Review Cell Biology

Posh the APC/C E3 Ubiquitin Licase to Orchestrate Cell Division

Edmond R. Watson et al.

TRENDS IN CELL BIOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

A novel human Cdh1 mutation impairs anaphase promoting complex/cyclosome activity resulting in microcephaly, psychomotor retardation, and epilepsy

Cristina Rodriguez et al.

JOURNAL OF NEUROCHEMISTRY (2019)

添加到收藏夹

Review Clinical Neurology

The basis of cellular and regional vulnerability in Alzheimer's disease

Dunja Mrdjen et al.

ACTA NEUROPATHOLOGICA (2019)

添加到收藏夹

Review Neurosciences

Targeting the Synapse in Alzheimer's Disease

Johanna Jackson et al.

FRONTIERS IN NEUROSCIENCE (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice

Olga Burmistrova et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Review Clinical Neurology

A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease

Francesco Panza et al.

NATURE REVIEWS NEUROLOGY (2019)

添加到收藏夹

Review Cell Biology

The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease

Ji Cheng et al.

AGING CELL (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cdh1 degradation is mediated by APC/C-Cdhi and SCF-Cdc4 in budding yeast

Masayoshi Nagai et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

添加到收藏夹

Article Psychiatry

Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression

Caroline Madeira et al.

FRONTIERS IN PSYCHIATRY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

New Functions of APC/C Ubiquitin Ligase in the Nervous System and Its Role in Alzheimer's Disease

Tanja Fuchsberger et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

添加到收藏夹

Review Neurosciences

Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis

Taro Kishi et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

添加到收藏夹

Article Multidisciplinary Sciences

APC/CCdh1-Rock2 pathway controls dendritic integrity and memory

Veronica Bobo-Jimenez et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

添加到收藏夹

Review Cell Biology

A decade of the anaphase-promoting complex in the nervous system

Ju Huang et al.

GENES & DEVELOPMENT (2016)

添加到收藏夹

Article Clinical Neurology

Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and infl ammation

Angel Chamorro et al.

LANCET NEUROLOGY (2016)

添加到收藏夹

Review Biochemistry & Molecular Biology

Building a Regulatory Network with Short Linear Sequence Motifs: Lessons from the Degrons of the Anaphase-Promoting Complex

Norman E. Davey et al.

MOLECULAR CELL (2016)

添加到收藏夹

Review Cell Biology

Insights into APC/C: from cellular function to diseases and therapeutics

Zhuan Zhou et al.

CELL DIVISION (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Aβ Induces Excitotoxicity Mediated by APC/C-Cdh1 Depletion That Can Be Prevented by Glutaminase Inhibition Promoting Neuronal Survival

T. Fuchsberger et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Cell Biology

The ABBA Motif Binds APC/C Activators and Is Shared by APC/C Substrates and Regulators

Barbara Di Fiore et al.

DEVELOPMENTAL CELL (2015)

添加到收藏夹

Article Neurosciences

Regulation of Bcl-xL-ATP Synthase Interaction by Mitochondrial Cyclin B1-Cyclin-Dependent Kinase-1 Determines Neuronal Survival

Miguel Veas-Perez de Tudela et al.

JOURNAL OF NEUROSCIENCE (2015)

添加到收藏夹

Article Neurosciences

A Cdh1-APC/FMRP Ubiquitin Signaling Link Drives mGluR-Dependent Synaptic Plasticity in the Mammalian Brain

Ju Huang et al.

NEURON (2015)

添加到收藏夹

Review Neurosciences

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease

Sergio T. Ferreira et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons

Miguel Veas-Perez de Tudela et al.

SCIENTIFIC REPORTS (2015)

添加到收藏夹

Article Neurosciences

The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution

Nico P. Dantuma et al.

Frontiers in Molecular Neuroscience (2014)

添加到收藏夹

Article Neurosciences

Rho Kinase Inhibitor Fasudil Protects against β-Amyloid-Induced Hippocampal Neurodegeneration in Rats

Yun Song et al.

CNS NEUROSCIENCE & THERAPEUTICS (2013)

添加到收藏夹

Article Neurosciences

Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-β Production in an Alzheimer's Disease Mouse Model

Jeremy H. Herskowitz et al.

JOURNAL OF NEUROSCIENCE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

APC/C-Cdh1 coordinates neurogenesis and cortical size during development

Maria Delgado-Esteban et al.

NATURE COMMUNICATIONS (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration

P. Rodriguez-Rodriguez et al.

CELL DEATH AND DIFFERENTIATION (2012)

添加到收藏夹

Article Clinical Neurology

Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy

Annapurna Poduri et al.

EPILEPSIA (2012)

添加到收藏夹

Article Neurosciences

Regulation of APC/C-Cdh1 and Its Function in Neuronal Survival

Angeles Almeida

MOLECULAR NEUROBIOLOGY (2012)

添加到收藏夹

Article Oncology

SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity

Hyun-Seok Kim et al.

CANCER CELL (2011)

添加到收藏夹

Article Neurosciences

The anaphase promoting complex is required for memory function in mice

Tanja Kuczera et al.

LEARNING & MEMORY (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation

Amar Sahay et al.

NATURE (2011)

添加到收藏夹

Article Neurosciences

APCCdh1 mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity

Amy K. Y. Fu et al.

NATURE NEUROSCIENCE (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes

Sergio L. Colombo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

添加到收藏夹

Article Cell Biology

The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1

Angel Herrero-Mendez et al.

NATURE CELL BIOLOGY (2009)

添加到收藏夹

Article Cell Biology

The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory

Min Li et al.

NATURE CELL BIOLOGY (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Retinoic acid downregulates Rae1 leading to APCCdh1 activation and neuroblastoma SH-SY5Y differentiation

J. Cuende et al.

ONCOGENE (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neuronal cell cycle re-entry mediates Alzheimer disease-type changes

Andrew McShea et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)

添加到收藏夹

Article Neurosciences

A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP

Rosalina Fonseca et al.

NEURON (2006)

添加到收藏夹

Review Cell Biology

The anaphase promoting complex/cyclosome: a machine designed to destroy

Jan-Michael Peters

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients

GS Burbaeva et al.

NEUROCHEMICAL RESEARCH (2005)

添加到收藏夹

Article Neurosciences

Cdh1/Hct1-APC is essential for the survival of postmitotic neurons

A Almeida et al.

JOURNAL OF NEUROSCIENCE (2005)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mammalian Cdh1/Fzr mediates its own degradation

T Listovsky et al.

EMBO JOURNAL (2004)

添加到收藏夹

Article Multidisciplinary Sciences

Cdh1-APC controls axonal growth and patterning in the mammalian brain

Y Konishi et al.

SCIENCE (2004)

添加到收藏夹

Article Cell Biology

Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway

A Almeida et al.

NATURE CELL BIOLOGY (2004)

添加到收藏夹

Article Biochemistry & Molecular Biology

Independent regulation of synaptic size and activity by the anaphase-promoting complex

P van Roessel et al.

CELL (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.